This review aims to look at the benefits and harms of various interventions used to increase deceased organ donor registration.
This is a protocol.
Interventions for increasing solid organ donor registration
You may also be interested in:
- Antifungal drugs used for prevention can significantly reduce the number of invasive fungal infections in liver transplant patients
- A comparison of the healthy donor's experience of donating their blood stem cells to a patient who is to receive a stem cell transplant as treatment for cancer of their blood (e.g. leukaemia)
- Pre-emptive treatment with antiviral agents can help to reduce the risk of cytomegalovirus disease
- Antiviral drugs used as protective and preventive therapy reduce CMV disease and CMV-associated deaths in solid organ transplant recipients
- Prophylaxis with Immunoglobulin G (IgG), anti CMV vaccine or interferon do not significantly reduce CMV disease and CMV-associated mortality in solid organ transplant recipients
Health topics: